A Study of BL-M11D1 in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Clinical trial NCT05924750 · RECRUITING

Trial details

NCT number: NCT05924750
Sponsor: Sichuan Baili Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)

Start date: 2023-08-02
Primary completion: 2026-12-01
Enrollment: 130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.